Edition:
India

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

73.21USD
23 Jan 2018
Change (% chg)

$-0.30 (-0.41%)
Prev Close
$73.51
Open
$73.50
Day's High
$73.88
Day's Low
$72.58
Volume
522,608
Avg. Vol
822,465
52-wk High
$84.13
52-wk Low
$54.67

Chart for

About

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear... (more)

Overall

Beta: 0.91
Market Cap(Mil.): $20,766.42
Shares Outstanding(Mil.): 315.22
Dividend: 0.46
Yield (%): 2.81

Financials

  Industry Sector
P/E (TTM): -- 21.06 16.62
EPS (TTM): -- -- --
ROI: -- 11.81 10.61
ROE: -- 13.97 14.21

BRIEF-Cordis And Medinol Announce FDA Approval Of EluNIR Drug-Eluting Stent System

* CORDIS AND MEDINOL ANNOUNCE FDA APPROVAL OF THE INNOVATIVE ELUNIR DRUG-ELUTING STENT SYSTEM Source text for Eikon: Further company coverage:

30 Nov 2017

UPDATE 3-Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

* Cardinal Health put business up for sale due to rule changes

15 Nov 2017

Shanghai Pharma buys U.S. Cardinal Health's China business for $557 mln

Nov 15 State-owned Shanghai Pharmaceuticals Holding Co has agreed to acquire Cardinal Health Inc's China business, one of the nation's largest drug distributors, for $557 million.

15 Nov 2017

BRIEF-Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​

* Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma

15 Nov 2017

BRIEF-Cardinal Health says shareholders re-elected all 11 members to board in preliminary voting ​

* Cardinal Health - ‍based on preliminary results of shareholder voting at co's annual meeting, shareholders re-elected all 11 members to board​ Source text for Eikon: Further company coverage:

09 Nov 2017

CORRECTED-UPDATE 1-Drug distributor Cardinal names Mike Kaufmann as new CEO

Nov 6 U.S. drug distributor Cardinal Health Inc on Monday named its chief financial officer as its next CEO, and reported a lower-than-expected quarterly revenue as it deals with stubbornly low prices for generic drugs.

06 Nov 2017

BRIEF-Cardinal Health Inc outlines leadership succession plan

* Cardinal Health Inc - ‍Jorge Gomez, CFO of Cardinal Health's medical segment, to succeed Kaufmann as chief financial officer​

06 Nov 2017

Drug distributor Cardinal's profit falls 63 pct

Nov 6 U.S. drug distributor Cardinal Health's quarterly profit fell nearly 63 percent, hurt by restructuring costs related to an agreement to directly distribute surgeon gloves in some markets.

06 Nov 2017

BRIEF-Cardinal Health reports Q1 GAAP earnings per share $0.36

* Cardinal Health Inc reports first-quarter results for fiscal year 2018

06 Nov 2017

Investor group presses U.S. drug companies on opioid controls

BOSTON U.S. shareholder activists are addressing a soaring death toll from opioid drug abuse, asking companies that make and distribute the painkillers to review the risks their businesses could face from their role in the sector.

30 Oct 2017

Competitors

  Price Chg
McKesson Corporation (MCK.N) $170.60 -2.36
AmerisourceBergen Corp. (ABC.N) $102.85 +0.19
Owens & Minor, Inc. (OMI.N) $21.57 -1.05

Earnings vs. Estimates